Effect of Desflurane and propofol on immune cell population in breast cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000939

Enrollment

Registered

2013-11-26

Start date

2013-09-23

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The patients were receive propofol or desflurane anesthesia using a computer-generated randomization table for a breast cancer surgery.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) aged 18 to 85 years 2) ASA (American society of anesthesiology) class I-III 3) Womens scheduled for mastectomy, axillary node dissection or wide local tumor excision in Ewha womans university Mokdong hospital .

Exclusion criteria

Exclusion criteria: 1) previous breast cancer surgery (except diagnostic biopsy) 2)inflammatory breast cancer, evidence of systemic infections (clinically defined or elevated C-reactive protein levels, leukocytosis, body temperature=37.8?) 3) any contraindication to midazolam, propofol, desflurane, fentanyl, rocuronium or nocuronium.

Design outcomes

Primary

Measure	Time frame
cytokine counts (IL-2/IL-4)	—

Secondary

Measure	Time frame
lymphocyte, leukocyte	—

Countries

Korea, Republic of

Contacts

Public ContactJae Hee Woo

Ewha Womans University Medical Center

shymoon83@gmail.com+82-2-2650-5285

Outcome results